Fig. 7From: Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptakeInhibition of [125I]MIBG uptake in isolated human platelets by different dilutions of murine plasma obtained from SSRI-treated mice. One hour before collecting plasma, mice intraperitoneally received the monoamine transporter inhibitor at the dose indicated in parenthesis. Data are from a representative experiment performed in duplicate and were confirmed by at least 2 experiments performed at slightly different conditionsBack to article page